Manufacturer:

GSK

Name:

BLENREP

Category:

J Code

HCPCS:

J9037

NDC(s):

00173-0896-01,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

BLENREP is a Cancer drug manufactured by GSK and administered via the Intravenous route of administration. The J Code: J9037 is aligned to the drug BLENREP.